Clinical trial
Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer
NCT00463489 · Ontario Clinical Oncology Group (OCOG), Other · Completed
Key facts
| NCT number | NCT00463489 |
|---|---|
| Title | Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer |
| Official title | Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer |
| Acronym | LISA |
| Lead sponsor | Ontario Clinical Oncology Group (OCOG), Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Behavioral |
| Interventions | Lifestyle intervention, Mail-based |
| Enrollment | 338 |
| Start date | Aug 1, 2007 |
| Primary completion | Jun 1, 2018 |
| Completion | Jun 1, 2018 |
| First posted | Apr 20, 2007 |
| Last update posted | Sep 26, 2018 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: